| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009077396 |
| P356 | DOI | 10.1186/1471-2407-8-149 |
| P932 | PMC publication ID | 2416360 |
| P698 | PubMed publication ID | 18507821 |
| P5875 | ResearchGate publication ID | 5342777 |
| P2093 | author name string | Luis O Gonzalez | |
| Francisco J Vizoso | |||
| Maria L Lamelas | |||
| Sara Junquera | |||
| Rosario Sanchez | |||
| Ana C Alvarez | |||
| Julio Vazquez | |||
| Maria D Corte | |||
| Juan C Rodriguez | |||
| P2860 | cites work | The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer | Q24803613 |
| Androgen and estrogen receptor mRNA status in apocrine carcinomas | Q74230751 | ||
| Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas | Q74590959 | ||
| Matrix metalloproteinases generate angiostatin: effects on neovascularization | Q77716097 | ||
| Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast | Q80417291 | ||
| Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer | Q83182311 | ||
| Androgen receptor activity in human breast cancer and its relationship with oestrogen and progestogen receptor activity | Q93572846 | ||
| Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression | Q28289323 | ||
| Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis | Q28344462 | ||
| New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
| Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention | Q33606833 | ||
| Matrix metalloproteinases: biologic activity and clinical implications | Q33849967 | ||
| Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression | Q33916687 | ||
| Decreased androgen receptor levels and receptor function in breast cancer contribute to the failure of response to medroxyprogesterone acetate. | Q34451293 | ||
| Complex roles of tissue inhibitors of metalloproteinases in cancer | Q34596110 | ||
| Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer | Q36138965 | ||
| Tissue inhibitor of metalloproteinases-1 in breast cancer | Q36157651 | ||
| Inhibition of the Akt, cyclooxygenase-2, and matrix metalloproteinase-9 pathways in combination with androgen deprivation therapy: potential therapeutic approaches for prostate cancer. | Q36207417 | ||
| Study of matrix metalloproteinases and their inhibitors in breast cancer | Q36610142 | ||
| Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse | Q36611308 | ||
| The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters | Q36831596 | ||
| Androgens and androgen receptors in breast cancer. | Q36882230 | ||
| Method for grading breast cancer | Q37232617 | ||
| Androgens induce divergent proliferative responses in human breast cancer cell lines. | Q38295844 | ||
| Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines | Q38310058 | ||
| The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells | Q38327469 | ||
| Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies. | Q38451314 | ||
| Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors | Q38485846 | ||
| Over expression of aromatase protein is highly related to MMPs levels in human breast carcinomas. | Q40318063 | ||
| Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors | Q40551882 | ||
| Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer. | Q40556992 | ||
| Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. | Q40838158 | ||
| The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture | Q42803269 | ||
| Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene. | Q43726313 | ||
| Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells. | Q44304193 | ||
| Androgen Receptor Expression in Estrogen Receptor-Negative Breast Cancer Immunohistochemical, Clinical, and Prognostic Associations | Q44649615 | ||
| Cysteine cathepsins (proteases)--on the main stage of cancer? | Q44897180 | ||
| Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma | Q46630833 | ||
| Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women | Q50867313 | ||
| Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. | Q51006975 | ||
| Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site. | Q51082512 | ||
| Immunohistochemical expression of androgen receptor and prostate-specific antigen in breast cancer | Q51786218 | ||
| Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray | Q52940878 | ||
| Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ. | Q54630457 | ||
| Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach | Q57089529 | ||
| Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment | Q68120466 | ||
| Sex hormone levels in serum in relation to the development of breast cancer | Q68980059 | ||
| Improved measurement of androgen receptors in human breast cancer | Q69384000 | ||
| Androgen receptors in breast cancer | Q70669192 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 149 | |
| P577 | publication date | 2008-05-28 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors | |
| P478 | volume | 8 |
| Q34550256 | A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. |
| Q34043711 | Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status |
| Q93177851 | Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies |
| Q37542959 | Androgen Receptor Expression in Breast Carcinoma of Egyptian Patients |
| Q42705600 | Androgen Receptor Expression in Thai Breast Cancer Patients |
| Q55431963 | Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - a Prospective Clinical Study. |
| Q33625672 | Androgen Receptor as a Potential Target for Treatment of Breast Cancer |
| Q40453986 | Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms. |
| Q38909264 | Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm |
| Q92331171 | Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer |
| Q34164902 | Androgen receptor expression and breast cancer survival in postmenopausal women |
| Q33776271 | Androgen receptor expression and its relationship with clinicopathological parameters in an Iranian population with invasive breast carcinoma |
| Q91287008 | Androgen receptor expression and response to chemotherapy in breast cancer patients treated in the neoadjuvant TECHNO and PREPARE trial |
| Q99415291 | Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma |
| Q35083868 | Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study |
| Q34309894 | Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations |
| Q57071354 | Androgen receptor expression in normal breast tissue and subsequent breast cancer risk |
| Q54451144 | Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers. |
| Q39364677 | Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck |
| Q43246075 | Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation |
| Q34068244 | Androgen receptor status predicts response to chemotherapy, not risk of breast cancer in Indian women |
| Q49283874 | Androgen receptor/let-7a signaling regulates breast tumor-initiating cells |
| Q38405459 | Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy |
| Q34995845 | Dietary lignan intake and androgen receptor expression in breast tumors |
| Q37481133 | Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer |
| Q36854062 | Emerging therapeutic targets in metastatic progression: A focus on breast cancer |
| Q34404655 | Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma |
| Q37690691 | Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines |
| Q53599776 | Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung |
| Q83837003 | Expression of 5α‐reductase in apocrine carcinoma of the breast and its correlation with clinicopathological aggressiveness |
| Q37229990 | Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer |
| Q36865089 | Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma |
| Q42480354 | Expression of androgen receptor in breast cancer and its significance as a prognostic factor |
| Q87451832 | Expression of androgen receptor in inflammatory breast cancer and its clinical relevance |
| Q46142414 | Expression of androgen receptor in mammary glands in ovariectomized cynomolgus monkeys |
| Q52723903 | Expression of hormone receptors in oropharyngeal squamous cell carcinoma |
| Q24652514 | Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature |
| Q35668330 | Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients |
| Q40164071 | Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer |
| Q36559266 | Identifying protein interaction subnetworks by a bagging Markov random field-based method. |
| Q64082215 | Immunohistochemical Expression of Androgen Receptors (AR) in Various Breast Cancer Subtypes |
| Q38673886 | In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines. |
| Q39942170 | Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis |
| Q33991012 | MMP-1 expression has an independent prognostic value in breast cancer |
| Q38962923 | MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression. |
| Q36113793 | Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? |
| Q33739841 | Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15. |
| Q57695773 | Molecular subtypes of breast cancer |
| Q51128232 | Multi-resolution-test for consistent phenotype discrimination and biomarker discovery in translational bioinformatics |
| Q37281532 | Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures |
| Q51071084 | Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression |
| Q64109813 | Prognostic and predictive value of androgen receptor expression in postmenopausal women with estrogen receptor-positive breast cancer: results from the Breast International Group Trial 1-98 |
| Q39499250 | Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis |
| Q90694564 | Radiopharmaceuticals for Breast Cancer and Neuroendocrine Tumors: Two Examples of How Tissue Characterization May Influence the Choice of Therapy |
| Q30419961 | Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice |
| Q37573317 | Role of the androgen receptor in triple-negative breast cancer |
| Q28244711 | Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation |
| Q33686275 | Seasonality pattern of breast, colorectal, and prostate cancer is dependent on latitude |
| Q35705826 | Synthesis and cytotoxicity studies of steroid-functionalized titanocenes as potential anticancer drugs: sex steroids as potential vectors for titanocenes |
| Q35607776 | The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients |
| Q34096288 | The Role of Androgens in Normal and Malignant Breast Tissue |
| Q38119251 | The Role of the Androgen Receptor in Triple-Negative Breast Cancer |
| Q35064269 | The impact of androgen receptor expression on breast cancer survival: a retrospective study and meta-analysis |
| Q36697482 | Tissue-Selective Regulation of Androgen-Responsive Genes |
Search more.